T. Aoi, K. Yae, M. Nakagawa, T. Ichisaka, and K. Okita, , vol.1

K. Takahashi, T. Chiba, and S. Yamanaka, Generation of pluripotent stem cells from adult mouse liver and stomach cells, Science, vol.321, pp.699-702, 2008.

R. Araki, M. Uda, Y. Hoki, M. Sunayama, .. M. Nakamura et al., Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells, Nature, vol.494, pp.100-104, 2013.

L. Aubry, A. Bugi, N. Lefort, F. Rousseau, .. M. Peschanski et al., Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats, Proc. Natl. Acad. Sci. USA, vol.105, pp.16707-16712, 2008.

A. Bachoud-lévi, H. M. Blau, C. P. Chiu, and C. Webster, Cytoplasmic activa-5. tion of human nuclear genes in stable heterocaryons, Lancet Neurol, vol.8, pp.1171-1180, 1983.

A. S. Boyd, N. P. Rodrigues, K. O. Lui, X. Fu, and Y. Xu, Concise review: Immune recognition of induced pluripotent stem cells, Stem Cells, vol.6, pp.797-803, 2012.

R. Briggs and T. J. King, Transplantation of living nuclei from 7. blastula cells into enucleated frogs' eggs, Proc. Natl. Acad. Sci, vol.38, pp.455-463, 1952.

P. Brundin, R. A. Barker, and M. Parmar, Neural grafting 8. in Parkinson's disease: Problems and possibilities, Prog. Brain Res, vol.184, pp.265-294, 2010.

B. W. Carey, S. Markoulaki, J. Hanna, K. Saha, M. Gao-;-mitalipova et al., Reprogramming of murine and human somatic cells using a single polycistronic vector, Proc. Natl. Acad. Sci, vol.106, pp.157-162, 2009.

M. Chang, D. Kim, C. Kim, H. Kang, .. E. Yang et al., Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning, Cell Stem Cell, vol.5, pp.171-178, 2002.

K. D. Fink, J. Rossignol, A. T. Crane, and T. D. Hulse, , p.13

X. Leveque, R. Wyse, D. J. Dues, L. D. Huffman, A. C. Moore et al., Transplantation of adenovirus-generated induced pluripotent stem cells into Huntington's disease striatum: Analysis of survival, differentiation, and recovery of function, Cell Transplant, vol.22, pp.353-357, 1990.

F. Gonzalez, M. Barragan-monasterio, G. Tiscornia, N. Montserrat-pulido, R. Vassena et al., Rodriguez Piza, I.; Izpisua Belmonte, J. C. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviralpolycistronic vector, Proc. Natl. Acad. Sci. USA, vol.16, pp.8918-8922, 2009.

J. D. Heng, B. Feng, J. Han, J. Jiang, P. Kraus et al., The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells, Cell Stem Cell, vol.6, pp.167-174, 2010.

R. Ho, C. Chronis, and K. Plath, Mechanistic insights into 18. reprogramming to induced pluripotency, J. Cell. Physiol, vol.226, pp.868-878, 2011.

D. Huangfu, K. Osafune, R. Maehr, W. Guo, .. A. Eijkelenboom et al., Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2, Nat. Biotechnol, vol.26, pp.1269-1275, 2008.

F. Jia, K. D. Wilson, N. Sun, D. M. Gupta, and M. Huang, , vol.20

Z. Li, N. J. Panetta, Z. Y. Chen, R. C. Robbins, M. A. Kay et al., A nonviral minicircle vector for deriving human iPS cells, Nat. Methods, vol.7, pp.197-199, 2010.

K. Kaji, K. Norrby, A. Paca, M. Mileikovsky, .. P. Mohseni et al., Virus-free induction of pluripotency and subsequent excision of reprogramming factors, Nature, vol.458, pp.771-775, 2009.

J. B. Kim, H. Zaehres, G. Wu, L. Gentile, and K. Ko, , vol.22

V. Sebastiano, M. J. Araúzo-bravo, D. Ruau, D. W. Han, M. Zenke et al., Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors, Nature, vol.454, pp.646-650, 2008.

J. L. Labandeira-garcia, K. Wictorin, . E. Cunningham, and A. Björklund, Development of intrastriatal striatal grafts TRANSPLANTATION OF ADENOVIRUS-GENERATED iPSCs 1423 and their afferent innervation from the host, Neuroscience, vol.23, pp.407-426, 1991.

L. Lescaudron, C. Boyer, V. Bonnamain, and K. D. Fink, , p.24

X. Lévêque, J. Rossignol, V. Nerrière-daguin, A. C. Malouet, F. Lelan et al., Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases, Methods Mol. Biol, vol.879, pp.147-164, 2012.

W. Li, W. Wei, S. Zhu, J. Zhu, Y. Shi et al., Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors, Cell Stem Cell, vol.4, pp.16-19, 2009.

R. Lister, M. Pelizzola, Y. S. Kida, R. D. Hawkins, .. J. Nery et al., Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells, Nature, vol.471, pp.68-73, 2011.

W. E. Lowry, L. Richter, R. Yachechko, and A. D. Pyle, , p.27

J. Tchieu, R. Sridharan, A. T. Clark, and K. Plath, Generation of human induced pluripotent stem cells from dermal fibroblasts, Proc. Natl. Acad. Sci, vol.105, pp.2883-2888, 2008.

L. Ma, Y. Liu, and S. Zhang, Directed differentiation of 28. dopamine neurons from human pluripotent stem cells, Methods Mol. Biol, vol.767, pp.411-418, 2011.

M. Nakagawa, M. Koyanagi, K. Tanabe, K. Takahashi, T. Ichisaka et al., Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts, Nat. Biotechnol, vol.29, pp.101-106, 2008.

T. H. Nguyen, M. Bellodi-privato, D. Aubert, ;. V. Pichard, A. Myara et al., Therapeutic lentivirusmediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats, Mol. Ther, vol.12, pp.852-859, 2005.

K. Niibe, Y. Kawamura, D. Araki, S. Morikawa, .. K. Miura et al., Purified mesenchymal stem cells are an efficient source for iPS cell induction, PLoS One, vol.6, 2011.

J. Nussbaum, E. Minami, M. A. Laflamme, and J. A. Virag, , vol.32

C. B. Ware, A. Masino, V. Muskheli, L. Pabon, H. Reinecke et al., Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response, FASEB J, vol.21, pp.1345-1357, 2007.

M. Ohnuki, K. Takahashi, and S. Yamanaka, Generation and 33. characterization of human induced pluripotent stem cells, Curr. Protoc. Stem Cell Biol, 2009.

K. Okita, T. Ichisaka, and S. Yamanaka, Generation of germline-34. competent induced pluripotent stem cells, Nature, vol.448, pp.313-317, 2007.

K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka, J. I. Pearl et al., Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors, Sci. Transl. Med, vol.35, pp.164-189, 2008.

J. Peng and X. Zeng, The role of induced pluripotent stem 37. cells in regenerative medicine: Neurodegenerative diseases, Stem Cell Res.Ther, vol.2, p.32, 2011.

J. Rossignol, C. Boyer, R. Thinard, S. Remy, .. Dugast et al., Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation, J. Cell. Mol. Med, vol.13, pp.2547-2558, 2009.

C. A. Sommer, M. Stadtfeld, G. J. Murphy, .. K. Hochedlinger, D. N. Kotton et al., Induced pluripotent stem cell generation using a single lentiviral stem cell cassette, Stem Cells, vol.27, pp.543-549, 2009.

M. Stadtfeld, E. Apostolou, H. Akutsu, and A. Fukuda, , vol.40

P. Follett, S. Natesan, T. Kono, T. Shioda, and K. Hochedlinger, Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells, Nature, vol.465, pp.175-181, 2010.

M. Stadtfeld, M. Nagaya, J. Utikal, and G. Weir, Hochedlinger, 41. K. Induced pluripotent stem cells generated without viral integration, Science, vol.322, pp.945-949, 2008.

K. Takahashi and S. Yamanaka, Induction of pluripotent stem 42. cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, vol.126, pp.663-676, 2006.

K. Y. Tan, S. Eminli, S. Hettmer, K. Hochedlinger, and A. J. Wagers, Efficient generation of iPS cells from skeletal muscle stem cells, PLoS One, vol.6, 2011.

M. Wernig, C. J. Lengner, J. Hanna, M. A. Lodato, .. E. Steine et al., A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types, Nat. Biotechnol, vol.26, pp.916-924, 2008.

M. Wernig, A. Meissner, R. Foreman, T. Brambrink, .. M. Ku et al., In vitro reprogramming of fibroblasts into a pluripotent ES-celllike state, Nature, vol.448, pp.318-324, 2007.

S. Yamanaka and H. M. Blau, Nuclear reprogramming to a 46. pluripotent state by three approaches, Nature, vol.465, pp.704-712, 2010.

Y. Zhang, L. Yao, X. Yu, J. Ou, N. Hui et al., A poor 47. imitation of a natural process: Acall to reconsider the iPSC engineering technique, Cell Cycle, vol.11, pp.4536-4544, 2012.

T. Zhao, Z. Zhang, Z. Rong, and Y. Xu, Immunogenicity 48. of induced pluripotent stem cells, Nature, vol.474, pp.212-215, 2011.